Pregnancy With Abortive Outcome — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for pregnancy with abortive outcome. 18 active patents protecting 1 drugs from 1+ originators. First major cliff: 2028. Daily refresh.

1
Approved drugs
18
Active US patents
47/100
Avg vulnerability
Annual revenue covered

Originators in Pregnancy With Abortive Outcome

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Corcept Therap 18 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating pregnancy with abortive outcome. Each bar = one year. Y-axis scaled to peak year (7 patents).

1
28
1
32
1
33
7
36
5
37
3
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Mifeprex
MIFEPRISTONE
Corcept Therap 18 47 2028-08-27

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8921348 Mifeprex method of use 58 2028-08-27
12097210 Mifeprex method of use 58 2037-06-19
11969435 Mifeprex method of use 58 2037-06-19
10842801 Mifeprex method of use 45 2032-11-15
10500216 Mifeprex method of use 45 2033-03-05
10166243 Mifeprex method of use 45 2036-04-20
10166242 Mifeprex method of use 45 2036-04-20
9943526 Mifeprex method of use 45 2036-04-20
10660904 Mifeprex method of use 45 2036-04-20
10495650 Mifeprex method of use 45 2036-08-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10314850 Mifeprex method of use 45 2038-08-22
10231983 Mifeprex method of use 45 2038-08-22
10780097 Mifeprex method of use 45 2038-08-22
10842800 Mifeprex method of use 45 2037-06-19
10195214 Mifeprex method of use 45 2037-06-19
10151763 Mifeprex method of use 45 2037-01-18
9829495 Mifeprex method of use 45 2036-08-15
10006924 Mifeprex method of use 45 2036-08-12
10495650 Mifeprex method of use 45 2036-08-12
10166243 Mifeprex method of use 45 2036-04-20

Related